Kevin Charles Gorman, Chief Executive Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 5,812 shares at $99.45 ($578K) on 2020-04-24, disclosed to the SEC on 2020-04-28.
Open-market sale of $578k NBIX by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $99.45 | 2,906 | $289K | 50.0% |
| 2 | $99.45 | 2,906 | $289K | 50.0% |
| Total | $99.45 avg | 5,812 | $578K | 100% |
| Filing → |
| NBIX | SELL | 2025-08-11 | $26.9M | — | Filing → |
| XNCR | SELL | 2025-06-16 | $29K | — | Filing → |
| NBIX | SELL | 2025-05-29 | $2.3M | — | Filing → |